The Keating Investment Counselors Inc. Has $386,000 Position in Becton, Dickinson and Company (BDX)

The Keating Investment Counselors Inc. Has $386,000 Position in Becton, Dickinson and Company (BDX)

Keating Investment Counselors Inc. maintained its stake in Becton, Dickinson and Company (NYSE:BDX) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,150 shares of the company’s stock at the end of the third quarter. Keating Investment Counselors Inc.’s holdings in Becton, Dickinson and Company were worth $386,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in BDX. Point72 Asia Hong Kong Ltd bought a new stake in Becton, Dickinson and Company during the second quarter valued at approximately $119,000. First PREMIER Bank increased its stake in Becton, Dickinson and Company by 251.0% in the third quarter. First PREMIER Bank now owns 839 shares of the company’s stock valued at $151,000 after buying an additional 600 shares during the period. ClariVest Asset Management LLC bought a new stake in Becton, Dickinson and Company during the second quarter valued at approximately $170,000. Tower Research Capital LLC TRC increased its stake in Becton, Dickinson and Company by 412.5% in the second quarter. Tower Research Capital LLC TRC now owns 1,025 shares of the company’s stock valued at $174,000 after buying an additional 825 shares during the period. Finally, Daiwa SB Investments Ltd. bought a new stake in Becton, Dickinson and Company during the third quarter valued at approximately $189,000. 81.14% of the stock is currently owned by institutional investors and hedge funds.

Becton, Dickinson and Company (NYSE:BDX) traded up 0.32% during trading on Wednesday, hitting $173.98. The stock had a trading volume of 909,925 shares. The company has a market cap of $36.94 billion, a price-to-earnings ratio of 38.75 and a beta of 1.00. The firm’s 50-day moving average price is $167.57 and its 200-day moving average price is $172.52. Becton, Dickinson and Company has a 52-week low of $129.50 and a 52-week high of $181.76.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.03. Becton, Dickinson and Company had a return on equity of 24.45% and a net margin of 7.82%. The company earned $3.23 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter in the previous year, the firm posted $1.94 EPS. The firm’s revenue was up 5.6% compared to the same quarter last year. Analysts predict that Becton, Dickinson and Company will post $9.48 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, December 30th. Shareholders of record on Friday, December 9th were given a dividend of $0.73 per share. The ex-dividend date of this dividend was Wednesday, December 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.68%. This is a boost from Becton, Dickinson and Company’s previous quarterly dividend of $0.66. Becton, Dickinson and Company’s payout ratio is currently 64.75%.

BDX has been the subject of several recent analyst reports. Zacks Investment Research upgraded Becton, Dickinson and Company from a “hold” rating to a “buy” rating and set a $189.00 price target for the company in a research note on Friday, November 25th. J P Morgan Chase & Co cut Becton, Dickinson and Company from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $190.00 to $175.00 in a research note on Tuesday, January 3rd. Argus restated a “buy” rating and issued a $185.00 price target on shares of Becton, Dickinson and Company in a research note on Friday, October 21st. Deutsche Bank AG restated a “buy” rating and issued a $189.00 price target (down previously from $197.00) on shares of Becton, Dickinson and Company in a research note on Friday, November 4th. Finally, RBC Capital Markets restated a “hold” rating and issued a $177.00 price target on shares of Becton, Dickinson and Company in a research note on Friday, January 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $176.39.

In other Becton, Dickinson and Company news, insider Stephen Sichak sold 10,352 shares of Becton, Dickinson and Company stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $176.10, for a total transaction of $1,822,987.20. Following the completion of the sale, the insider now owns 26,892 shares of the company’s stock, valued at approximately $4,735,681.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP John E. Gallagher sold 1,793 shares of Becton, Dickinson and Company stock in a transaction dated Thursday, December 15th. The stock was sold at an average price of $168.82, for a total value of $302,694.26. Following the sale, the vice president now directly owns 2,796 shares of the company’s stock, valued at approximately $472,020.72. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Related posts

Leave a Comment